<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37053125</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>397</EndPage><MedlinePgn>391-397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7215a3</ELocationID><Abstract><AbstractText>Since the Global Polio Eradication Initiative (GPEI) began in 1988, the number of wild poliovirus (WPV) cases has declined by &gt;99.99%. Five of the six World Health Organization (WHO) regions have been certified free of indigenous WPV, and WPV serotypes 2 and 3 have been declared eradicated globally (1). WPV type 1 (WPV1) remains endemic only in Afghanistan and Pakistan (2,3). Before the outbreak described in this report, WPV1 had not been detected in southeastern Africa since the 1990s, and on August 25, 2020, the WHO African Region was certified free of indigenous WPV (4). On February 16, 2022, WPV1 infection was confirmed in one child living in Malawi, with onset of paralysis on November 19, 2021. Genomic sequence analysis of the isolated poliovirus indicated that it originated in Pakistan (5). Cases were subsequently identified in Mozambique. This report summarizes progress in the outbreak response since the initial report (5). During November 2021-December 2022, nine children and adolescents with paralytic polio caused by WPV1 were identified in southeastern Africa: one in Malawi and eight in Mozambique. Malawi, Mozambique, and three neighboring countries at high risk for WPV1 importation (Tanzania, Zambia, and Zimbabwe) responded by increasing surveillance and organizing up to six rounds of national and subnational polio supplementary immunization activities (SIAs).* Although no cases of paralytic WPV1 infection have been reported in Malawi since November 2021 or in Mozambique since August 2022, undetected transmission might be ongoing because of poliovirus surveillance gaps and testing delays. Efforts to further enhance poliovirus surveillance sensitivity, improve SIA quality, and strengthen routine immunization are needed to ensure that WPV1 transmission has been interrupted within 12 months of the first case, thereby preserving the WHO African Region's WPV-free status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davlantes</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Sharon A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Tobolowsky</LastName><ForeName>Farrell A</ForeName><Initials>FA</Initials></Author><Author ValidYN="Y"><LastName>Biya</LastName><ForeName>Oladayo</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Wiesen</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Abebe</LastName><ForeName>Fikru</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Weldetsadik</LastName><ForeName>Mesfin B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Eboh</LastName><ForeName>Victor A</ForeName><Initials>VA</Initials></Author><Author ValidYN="Y"><LastName>Chisema</LastName><ForeName>Mike N</ForeName><Initials>MN</Initials></Author><Author ValidYN="Y"><LastName>da Conceição Mário</LastName><ForeName>Balbina</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Tinuga</LastName><ForeName>Florian</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Bobo</LastName><ForeName>Patricia Mupeta</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Chigodo</LastName><ForeName>Colline Koline</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Sethy</LastName><ForeName>Ghanashyam</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Hellström</LastName><ForeName>Jan-Marcus</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Goundara</LastName><ForeName>Abdou Moumouni</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Burny</LastName><ForeName>Marie-Eve</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Mwale</LastName><ForeName>Jonas C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Jorba</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Makua</LastName><ForeName>Koketso S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Wayne</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Seakamela</LastName><ForeName>Lerato</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Okiror</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Asma</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Samba</LastName><ForeName>Dhoud</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Agbo</LastName><ForeName>Chukwuemeka</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kabamba</LastName><ForeName>Lusamba</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kazoka</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zomahoun</LastName><ForeName>Delayo Laurel</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Manneh</LastName><ForeName>Fadinding</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Abdelrahim</LastName><ForeName>Khalid</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kamugisha</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Umar</LastName><ForeName>Abubakar Sadiq</ForeName><Initials>AS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008295" MajorTopicYN="N" Type="Geographic">Malawi</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Wayne Howard and Koketso S. Makua report institutional support from the World Health Organization (WHO) and the Bill &amp; Melinda Gates Foundation, donation of equipment and reagents by WHO, and uncompensated membership on the National Polio Expert Committee—South Africa. No other potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37053125</ArticleId><ArticleId IdType="pmc">PMC10121257</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7215a3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. Progress toward polio eradication—worldwide, January 2019–June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1129–35. 10.15585/mmwr.mm7034a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7034a1</ArticleId><ArticleId IdType="pmc">PMC8389387</ArticleId><ArticleId IdType="pubmed">34437527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Baig S, Khan Z, et al. Progress toward poliomyelitis eradication—Pakistan, January 2020–July 2021. MMWR Morb Mortal Wkly Rep 2021;70:1359–64. 10.15585/mmwr.mm7039a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7039a1</ArticleId><ArticleId IdType="pmc">PMC8486386</ArticleId><ArticleId IdType="pubmed">34591827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed A, Akbar IE, Chaudhury S, et al. Progress toward poliomyelitis eradication—Afghanistan, January 2021–September 2022. MMWR Morb Mortal Wkly Rep 2022;71:1541–6. 10.15585/mmwr.mm7149a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7149a1</ArticleId><ArticleId IdType="pmc">PMC9762895</ArticleId><ArticleId IdType="pubmed">36480464</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomban Leke RG, King A, Pallansch MA, et al.; Africa Regional Commission for the Certification of Poliomyelitis Eradication. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health 2020;8:e1345–51. 10.1016/S2214-109X(20)30382-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30382-X</ArticleId><ArticleId IdType="pmc">PMC7525084</ArticleId><ArticleId IdType="pubmed">32916086</ArticleId></ArticleIdList></Reference><Reference><Citation>Malawi Ministry of Health; Global Polio Eradication Initiative; Davlantes E. Notes from the field: initial outbreak response activity following wild poliovirus type 1 detection—Malawi, February 2022. MMWR Morb Mortal Wkly Rep 2022;71:776–7. 10.15585/mmwr.mm7123a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7123a3</ArticleId><ArticleId IdType="pmc">PMC9181050</ArticleId><ArticleId IdType="pubmed">35679180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson AL, Diop OM, Jorba J, Gardner T, Snider CJ, Ahmed J. Surveillance to track progress toward polio eradication—worldwide, 2020–2021. MMWR Morb Mortal Wkly Rep 2022;71:538–44. 10.15585/mmwr.mm7115a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7115a2</ArticleId><ArticleId IdType="pmc">PMC9020859</ArticleId><ArticleId IdType="pubmed">35421079</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigouette JP, Henderson E, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2021–December 2022. MMWR Morb Mortal Wkly Rep 2023;72:366–71. 10.15585/mmwr.mm7214a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7214a3</ArticleId><ArticleId IdType="pmc">PMC10078846</ArticleId><ArticleId IdType="pubmed">37022974</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>